An observational study in Epiretinal Membranes, Retinal Detachment and Full Thickness Macular Hole, sponsored by Prim. Prof. Dr. Oliver Findl, MBA. Active, not recruiting at 1 site in Austria. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-20.
Sponsored by Prim. Prof. Dr. Oliver Findl, MBA · Observational
Subtenonal anesthesia is a well-known technique of local anesthesia for patients undergoing pars plana vitrectomies. It was described to be efficient with respect to anesthesia of the eye and it showed less risks compared to retrobulbar or parabulbar anesthesia. Purpose of the study is to assess subjective pain scores of patients, that underwent vitrectomy with subtenonal anesthesia.
Subtenonal anesthesia is a well-known technique of local anesthesia for patients undergoing pars plana vitrectomies. It was described to be efficient with respect to anesthesia of the eye and it showed less risks compared to retrobulbar or parabulbar anesthesia. Subjective pain scores of patients, that underwent vitrectomy with subtenonal anesthesia, are probably different among patients with excessive indentation of the bulbus for retinal detachment repair, compared to patients undergoing vitrectomy with membrane peeling for epiretinal membranes or full thickness macular holes. Purpose of the study is to assess subjective pain scores of patients, that underwent vitrectomy with subtenonal anesthesia.
130 studies on the registry are indexed under Epiretinal Membrane; 18 are open to participants now.
This study's enrollment of 70 is above the median of 60 across 48 observational studies indexed under Epiretinal Membrane.
Browse Epiretinal Membrane studies →Prim. Prof. Dr. Oliver Findl, MBA is the lead sponsor of 39 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients having undergone vitrectomy in subtenon´s anesthesia
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria
Any of the following will exclude a subject from the study:
patients with the indications epiretinal membranes or full thickness macular holes are belonging to the Group of vitreoretnal surface diseases
Other: subjective pain score assessment
patients with the indication retinal detachment are belonging to this group
Other: subjective pain score assessment
a questionnaire assessing subjective pain during surgery, using the Visual Analogue Scale with values from 0 to 10
subjective pain score during surgery
subjective pain score during surgery are assessed with Visual Analogue Scale from 0 to 10. The value of 0 represents no pain and the value of 10 represents the highest pain that can be imagined.
Time frame: assessed within 24 hours sfter surgery
Plan to share: No
Started Dec 2023 (actual). Primary completion is estimated for May 2025, 17 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Prim. Prof. Dr. Oliver Findl, MBA